Anti-SRCA/ SRL/ SAR monoclonal antibody

Anti-SRCA/ SRL/ SAR antibody for FACS & in-vivo assay

Target products collectionGo to SRL/SRL products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2604-Ab-1/ GM-Tg-hg-MP2604-Ab-2Anti-Human SRL monoclonal antibodyHuman
GM-Tg-rg-MP2604-Ab-1/ GM-Tg-rg-MP2604-Ab-2Anti-Rat SRL monoclonal antibodyRat
GM-Tg-mg-MP2604-Ab-1/ GM-Tg-mg-MP2604-Ab-2Anti-Mouse SRL monoclonal antibodyMouse
GM-Tg-cynog-MP2604-Ab-1/ GM-Tg-cynog-MP2604-Ab-2Anti-Cynomolgus/ Rhesus macaque SRL monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2604-Ab-1/ GM-Tg-felg-MP2604-Ab-2Anti-Feline SRL monoclonal antibodyFeline
GM-Tg-cang-MP2604-Ab-1/ GM-Tg-cang-MP2604-Ab-2Anti-Canine SRL monoclonal antibodyCanine
GM-Tg-bovg-MP2604-Ab-1/ GM-Tg-bovg-MP2604-Ab-2Anti-Bovine SRL monoclonal antibodyBovine
GM-Tg-equg-MP2604-Ab-1/ GM-Tg-equg-MP2604-Ab-2Anti-Equine SRL monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2604-Ab-1/ GM-Tg-hg-MP2604-Ab-2; GM-Tg-rg-MP2604-Ab-1/ GM-Tg-rg-MP2604-Ab-2;
GM-Tg-mg-MP2604-Ab-1/ GM-Tg-mg-MP2604-Ab-2; GM-Tg-cynog-MP2604-Ab-1/ GM-Tg-cynog-MP2604-Ab-2;
GM-Tg-felg-MP2604-Ab-1/ GM-Tg-felg-MP2604-Ab-2; GM-Tg-cang-MP2604-Ab-1/ GM-Tg-cang-MP2604-Ab-2;
GM-Tg-bovg-MP2604-Ab-1/ GM-Tg-bovg-MP2604-Ab-2; GM-Tg-equg-MP2604-Ab-1/ GM-Tg-equg-MP2604-Ab-2
Products NameAnti-SRL monoclonal antibody
Formatmab
Target NameSRL
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SRL benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species SRCA/ SRL/ SAR VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP001800human SRL Lentivirus particle
    ORF Viral VectorpGMLP001800human SRL Lentivirus plasmid
    ORF Viral VectorpGMLPm004094mouse Srl Lentivirus plasmid
    ORF Viral VectorvGMLPm004094mouse Srl Lentivirus particle


    Target information

    Target IDGM-MP2604
    Target NameSRL
    Gene ID6345,106393,302948,704655,101095708,513912,100069703
    Gene Symbol and Synonyms9830004M20Rik,SAR,SRL
    Uniprot AccessionQ86TD4
    Uniprot Entry NameSRCA_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000185739
    Target ClassificationN/A

    The target: SRL, gene name: SRL, also named as SAR. Predicted to enable GTP binding activity. Predicted to be involved in endocytosis and endosomal transport. Predicted to act upstream of or within response to muscle activity involved in regulation of muscle adaptation and store-operated calcium entry. Predicted to be located in sarcoplasmic reticulum lumen and sarcoplasmic reticulum membrane. Predicted to be active in intracellular membrane-bounded organelle. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.